Afatinib for the treatment of EGFR mutation-positive NSCLC: A review of clinical findings

R. Donald Harvey, Val R. Adams, Tyler Beardslee, Patrick Medina

Research output: Contribution to journalReview articlepeer-review

77 Citations (SciVal)

Fingerprint

Dive into the research topics of 'Afatinib for the treatment of EGFR mutation-positive NSCLC: A review of clinical findings'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science